Bhopal Newspaper

Hereditary Angioedema Market, Size, Share, Trends, Epidemiology Forecast till 2030

 Breaking News
  • No posts were found

Hereditary Angioedema Market, Size, Share, Trends, Epidemiology Forecast till 2030

July 21
15:32 2020
Hereditary Angioedema Market, Size, Share, Trends, Epidemiology Forecast till 2030

DelveInsight Business Research LLP
DelveInsight’s “Hereditary Angioedema Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Hereditary Angioedema , historical and forecasted epidemiology as well as the Hereditary Angioedema market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Hereditary Angioedema is a rare, potentially life-threatening inherited disorder with symptoms of severe, painful, and recurring attacks of oedema (swelling). Hereditary Angioedema patients often suffer for many years and may be subject to unnecessary medical procedures and surgery before receiving an accurate diagnosis. Therapy for Hereditary Angioedema can be generally divided into two approaches, acute (or on-demand) treatment of attacks and prevention of attacks, which is broken down into short-term prophylaxis (STP) and long-term prophylaxis (LTP).

 

The epidemiology facts of Hereditary Angioedema market report
1. Hereditary Angioedema affects one in 50,000 individuals in the United States.
2. Hereditary Angioedema prevalence in Japan is estimated to be 4.1 per 10 million people.
3. Hereditary Angioedema is more prevalent among females than males.

 

Request for sample pages

 

 

 

 

Scope of the Report

 

  • The report covers the descriptive overview of Hereditary Angioedema , explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Hereditary Angioedema epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Hereditary Angioedema are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Hereditary Angioedema market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Hereditary Angioedema market

 

Table of contents

 

Table of contents
1. Report Introduction
2. Hereditary Angioedema Market Overview at a Glance
3. Disease Background and Overview: Hereditary Angioedema
4. Hereditary Angioedema Epidemiology and Patient Population
5. Hereditary Angioedema Country-Wise Epidemiology
5.1. United States
5.2. EU-5
5.2.1. Assumptions and Rationale
5.2.2. Germany
5.2.3. France
5.2.4. Italy
5.2.5. Spain
5.2.6. United Kingdom
5.3. Japan
6. Hereditary Angioedema Treatments & Medical Practices
7. Hereditary Angioedema Marketed Therapies
7.1. Key Cross Competition
7.2. Berinert: CSL Behring
7.3. Takhzyro: Takeda
8. Hereditary Angioedema Emerging Therapies
8.1. Key Cross Competition
8.2. BCX7353: BioCryst Pharmaceuticals
8.3. IONIS-PKK-LRx: Ionis Pharmaceuticals
8.4. ATN-249: Attune Pharma
9. Hereditary Angioedema Market Size
9.1. Key Findings
9.2. Total 7MM Hereditary Angioedema Market Analysis
10. 7MM: Country-Wise Market Analysis
10.1. United States Market Size
10.2. EU-5
10.2.1. Germany Market Size
10.2.2. France Market Size
10.2.3. Italy Market Size
10.2.4. Spain Market Size
10.2.5. United Kingdom Market Size
10.3. Japan Market Size
11. Hereditary Angioedema Market Drivers
12. Hereditary Angioedema Market Barriers
13. Appendix
14. Hereditary Angioedema Report Methodology
15. DelveInsight Capabilities
16. Disclaimer
17. About DelveInsight

Media Contact
Company Name: DelveInsight
Contact Person: Priya Maurya
Email: Send Email
Phone: +919650213330
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

Related Articles